Biogen
BIIB
BIIB
1,048 hedge funds and large institutions have $37.1B invested in Biogen in 2020 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 309 increasing their positions, 433 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less call options, than puts
Call options by funds: $1.42B | Put options by funds: $1.53B
14% less funds holding in top 10
Funds holding in top 10: 21 → 18 (-3)
29% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 433
Holders
1,048
Holding in Top 10
18
Calls
$1.42B
Puts
$1.53B
Top Buyers
| 1 | +$89.8M | |
| 2 | +$89.4M | |
| 3 | +$85.2M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$71.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$48M |
Top Sellers
| 1 | -$161M | |
| 2 | -$150M | |
| 3 | -$135M | |
| 4 |
Goldman Sachs
New York
|
-$128M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$118M |